NCT06210711 Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
| NCT ID | NCT06210711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Traumatic Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-02-28 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-02-28 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18 and 75 years old. * Admitted to Baylor University Medical Center at Dallas (BUMC), Baylor Scott \& White Medical Center at Temple (BSWMC), or Froedtert Hospital and the Medical College of Wisconsin (FH/MCW) Level 1 Trauma Center Exclusion Criteria: * Patients in police custody * Patients not fluent in English * Patients with severe cognitive impairment * Patients who are acutely suicidal * Patients with active psychosis
Contact & Investigator
Ann Marie Warren, PhD
PRINCIPAL INVESTIGATOR
Baylor Scott & White Research Institute
Frequently Asked Questions
Who can join the NCT06210711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Traumatic Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06210711 currently recruiting?
Yes, NCT06210711 is actively recruiting participants. Contact the research team at Alexis.Evans@BSWHealth.org for enrollment information.
Where is the NCT06210711 trial being conducted?
This trial is being conducted at Dallas, United States, Temple, United States, Milwaukee, United States.
Who is sponsoring the NCT06210711 clinical trial?
NCT06210711 is sponsored by Baylor Research Institute. The principal investigator is Ann Marie Warren, PhD at Baylor Scott & White Research Institute. The trial plans to enroll 300 participants.